Compliance Group Advances AI Governance for Life Sciences to Enable Responsible AI Adoption
Artificial Intelligence has moved from pilot projects to mission-critical quality, regulatory, and manufacturing applications across life sciences. But as organizations accelerate AI adoption, one question is becoming impossible to ignore:
“Who is governing the AI?”
While many technology vendors claim to offer "AI governance," very few organizations have established the processes, controls, accountability, and lifecycle oversight needed to demonstrate that AI decisions are trustworthy, explainable, controlled, and inspection-ready. Compliance Group (CG) believes the conversation must move beyond AI adoption to AI accountability.
As one of the few life sciences compliance organizations to achieve ISO/IEC 42001:2023 certification for its Artificial Intelligence Management System (AIMS), Compliance Group brings together AI governance expertise with deep life sciences domain knowledge. We understand that regulated organizations must navigate not only enterprise AI governance expectations, but also an evolving regulatory landscape that includes the EU AI Act, emerging EU GMP Annex 22 expectations for Artificial Intelligence, FDA guidance and directions on AI-enabled systems like GAMP guidance, NIST AI RMF, data privacy requirements, cybersecurity obligations, and established GxP expectations for validation of computerized systems in a GxP environment.
